Atenolol 50 mg is absolutely contraindicated in a 75-year-old patient with severe bradycardia (heart rate 30 bpm)
Do not administer atenolol or any beta-blocker to this patient. Beta-blockers like atenolol cause bradycardia as a primary adverse effect and will worsen this patient's already critically low heart rate, potentially leading to cardiac arrest 1.
Immediate Management Required
This patient requires urgent treatment for symptomatic bradycardia, not rate-lowering medications:
First-Line Treatment
- Atropine 0.5-1 mg IV is the initial drug of choice for symptomatic bradycardia 2, 3, 4, 5
- Can repeat every 3-5 minutes up to maximum 3 mg 5
- Works by blocking parasympathetic tone to increase heart rate
If Atropine Fails
Consider second-line agents 3, 5:
- Dopamine infusion: 5-20 mcg/kg/min IV
- Epinephrine infusion: 2-10 mcg/min IV
- Transcutaneous pacing while preparing for transvenous pacing if needed 2, 4
Why Beta-Blockers Are Dangerous Here
The FDA drug label explicitly states that bradycardia is a known adverse effect of atenolol 1. Multiple guidelines list beta-blockers as causing bradycardia and hypotension 2. Clinical practice guidelines specifically identify symptomatic bradycardia as a contraindication to beta-blocker therapy 6.
Key contraindications from guidelines 7, 8:
- AV block greater than first degree or SA node dysfunction (without pacemaker)
- Symptomatic bradycardia or hypotension
- Decompensated heart failure
Research confirms the danger: A case report documented a 65-year-old patient who developed syncope, severe bradycardia, and ECG pauses requiring hospitalization when treated with atenolol 9. Another case described life-threatening cardiovascular collapse requiring CPR in a patient with atenolol overdose 10.
Clinical Context
At a heart rate of 30 bpm, this patient is experiencing severe, potentially life-threatening bradycardia. The 2010 AHA guidelines define clinically significant bradycardia as typically <50 bpm 2. This patient is well below that threshold and requires immediate intervention to increase heart rate, not further suppress it.
Common Pitfall to Avoid
Never administer rate-lowering medications (beta-blockers, calcium channel blockers, digoxin) to patients with existing bradycardia unless they have a functioning pacemaker. The elderly are particularly vulnerable to drug-related bradycardia, with beta-blockers being the most common culprit 11.
The priority is stabilizing the heart rate first. Only after achieving hemodynamic stability and normal heart rate should any consideration be given to rate-control medications, and even then, only if there is a specific indication (like atrial fibrillation or hypertension) that outweighs the risks.